Chemical Compound

salmeterol xinafoate

CAS Registry Number 94749-08-3
salmeterol xinafoate chemical structure
Primary Record

salmeterol xinafoate

In stock
9,762 g
Purity
98.6 %
CAS
94749-08-3

Compound Identifiers & Properties

CAS
94749-08-3
PubChem CID
56801
SMILES
C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O.C1=CC=C2C(=C1)C=CC(=C2O)C(=O)O
Canonical SMILES
O=C(O)c1ccc2ccccc2c1O.OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O

Names & Synonyms

  • salmeterol xinafoate
  • Serevent
  • Salmetedur
  • 94749-08-3
  • Arial
  • Serevent diskus
  • Betamican
  • SALMETEROLO
  • Ultrabeta
  • Asmerole
  • Dilamax
  • Inaspir
  • Beglan
  • Siduomi
  • Salmeterolxinafoate
  • Salmetedur;
  • Betamican;
  • Aeromax;
  • Inaspir;
  • Beglan;
  • Arial;
  • Salmeterol xinafonate
  • Serevent (TN)
  • Salmeterol (xinafoate)
  • GR 33343X xinafoate
  • Salmeterol 1-hydroxy-2-naphthoate
  • Salmeterol xinafoate?
  • Xinafoate, Salmeterol
  • Serevent Inhaler and Disks
  • Salmeterol xinafoate [USAN]
  • RefChem:56524
  • Salmeterol xinafoate CRS
  • AC1L1LPS
  • GR 33343 G
  • DTXSID1045798
  • gr-33343g
  • MFCD00897708
  • Advair Diskus 100/50
  • Advair Diskus 250/50
  • Advair Diskus 500/50
  • Salmeterol Hydroxynaphthoate
  • UNII-6EW8Q962A5
  • 6EW8Q962A5
  • SCHEMBL18070
  • DTXCID9025798
  • C36H45NO7
  • MLS001332577
  • MLS001332578
  • Salmeterol xinafoate [USAN:USP]
  • CHEBI:9012
  • LIPO-202
  • orb1300582
  • SCHEMBL2833182
  • CHEMBL1082607
  • GR-33343 G
  • salmeterol, 1-hydroxy-2-naphthoate
  • SCHEMBL29352164
  • SCHEMBL29372524
  • C25H37NO4.C11H8O3
  • CTK8B9015
  • Salmeterol xinafoate (JAN/USP)
  • 94749-08-3 (xinafoate)
  • GR-33343X
  • XTZNCVSCVHTPAI-UHFFFAOYSA-N
  • HMS2232I16
  • HMS3263K22
  • HMS3676P13
  • HMS3749I03
  • HMS3885J19
  • HMS5083C07
  • Salmeterol (xinafoate) (Standard)
  • SALMETEROL XINAFOATE [JAN]
  • AMY23373
  • BCP04778
  • CID56801
  • GR 3343G
  • Salmeterol 1-hydr oxy-2-naphthoate
  • SALMETEROL XINAFOATE [VANDF]
  • Tox21_111270
  • Tox21_501100
  • ANW-61823
  • EBC-97122
  • GR 33343G
  • HY-17453R
  • MSK000735
  • NCGC00094372-03
  • s4296
  • SALMETEROL XINAFOATE [MART.]
  • SN 408
  • SALMETEROL XINAFOATE [USP-RS]
  • SALMETEROL XINAFOATE [WHO-DD]
  • AKOS016004957
  • Tox21_111270_1
  • 4-(1-Hydroxy-2-((6-(4-phenylbutoxy)hexyl)amino)ethyl)-2-(hydroxymethyl)phenol 1-hydroxy-2-naphthoate
  • ACN-040066
  • AN-8181
  • CCG-270203
  • CS-1527
  • FS27784
  • KS-1140
  • LP01100
  • MSK000735-100M
  • ADVAIR COMPONENT SALMETEROL XINAFOATE
  • NCGC00015938-05
  • NCGC00094372-01
  • NCGC00094372-02
  • NCGC00094372-04
  • NCGC00261785-01
  • 4CA-1124
  • BC208521
  • HY-17453
  • LS-94516
  • SALMETEROL XINAFOATE [EP IMPURITY]
  • SALMETEROL XINAFOATE [ORANGE BOOK]
  • SMR000875207
  • SY047289
  • BCP0726000003
  • SALMETEROL XINAFOATE [EP MONOGRAPH]
  • 2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol;1-hydroxynaphthalene-2-carboxylic acid
  • AB0020656
  • CAS-94749-08-3
  • DB-057527
  • SALMETEROL XINAFOATE [USP MONOGRAPH]
  • TC-150568
  • A3190
  • C25-H37-N-O4.C11-H8-O3
  • EU-0101100
  • FT-0642283
  • NS00076193
  • ST24031610
  • V1621
  • Salmeterol xinafoate, >=98% (HPLC), solid
  • D00687
  • LIPO-102 COMPONENT SALMETEROL XINAFOATE
  • R10007
  • SALMETEROL 1-HYDROXY-2-NAPHTHOATE [MI]
  • Salmeterol xinafoate for system suitability CRS
  • W-5199
  • ADVAIR HFA COMPONENT SALMETEROL XINAFOATE
  • AIRDUO RESPICLICK COMPONENT SALMETEROL XINAFOATE
  • Salmeterol xinafoate for peak identification CRS
  • A916443
  • SR-01000597359
  • SR-01000597359-1
  • Q27264747
  • Salmeterol Xinafoate Solution in Methanol, 100ug/mL
  • B0084-079988
  • (+-)-4-Hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-m-xylene-alpha,alpha'-diol 1-hydroxy-2-naphthoate (salt)
  • Salmeterol xinafoate, European Pharmacopoeia (EP) Reference Standard
  • (+/-) 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol xinafoate
  • 1,3-Benzenedimethanol, 4-hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-, (+-)-, 1-hydroxy-2-naphthalenecarboxylate (salt)
  • 2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol; 1-hydroxynaphthalene-2-carboxylic acid
  • Salmeterol xinafoate, United States Pharmacopeia (USP) Reference Standard
  • Salmeterol xinafoate for system suitability, European Pharmacopoeia (EP) Reference Standard
  • Salmeterol Xinafoate, Pharmaceutical Secondary Standards; Certified Reference Material
  • ( inverted exclamation markA) 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol xinafoate
  • (+/-)-4-HYDROXY-.ALPHA.(SUP 1)-(((6-(4-PHENYLBUTOXY)HEXYL)AMINO)METHYL)-M-XYLENE-.ALPHA.,.ALPHA.'-DIOL 1-HYDROXY-2-NAPHTHOATE
  • 1,3-BENZENEDIMETHANOL, 4-HYDROXY-.ALPHA.(SUP 1)-(((6-(4-PHENYLBUTOXY)HEXYL)AMINO)METHYL)-, (+/-)-, 1-HYDROXY-2-NAPHTHALENECARBOXYLATE
  • 1-Hydroxynaphthalene-2-carboxylic acid--2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol (1/1)
  • 2-(Hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol 1-hydroxy-2-naphthoate
  • 2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol,1-hydroxynaphthalene-2-carboxylic acid
  • 4-[1-Hydroxy-2-[[6-(4-phenylbutoxy)hexyl]amino]ethyl]-2-(hydroxymethyl)phenol 1-Hydroxy-2-naphthoate
  • 4-[1-Hydroxy-2-[[6-(4-phenylbutoxy)hexyl]amino]ethyl]-2-(hydroxymethyl)phenol compd. with 1-Hydroxy-2-naphthoic Acid (1:1)
  • 4-Hydroxy-?1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol 1-hydroxy-2-naphthalenecarboxylic acid
  • 4-Hydroxy-?1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol 1-hydroxy-2-naphthalenecarboxylic acid salt
  • 4-Hydroxy-|A1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol 1-Hydroxy-2-naphthalenecarboxylic Acid
  • Salmeterol Xinafoate; (1RS)-1-[4-Hydroxy-3-(Hydroxymethyl)phenyl]-2-[[6-(4-phenylbutoxy)hexyl]amino]ethanol 1-hydroxynaphthalene-2-carboxylate; GR 33343G; GR 33343G